XORTX to Present at BIO 2024

June 04, 2024, XORTX Therapeutics Inc. , a late-stage clinical pharmaceutical firm focused on innovative treatments for progressive kidney disease, has announced its participation in the BIO International Convention 2024, scheduled from June 3rd through 6th, 2024. Dr. Allen Davidoff, the CEO of XORTX, will present an overview of the company, highlighting current progress and future regulatory and clinical plans.

Dr. Davidoff expressed enthusiasm for the event, noting, "This marks the second invitation for XORTX to present at the BIO International Convention. The presentation and associated meetings provide a vital opportunity for engaging with pharmaceutical partners, licensing contacts, and industry stakeholders. We anticipate a productive week, with over 25 meetings lined up."

The four-day convention, dedicated to biotechnology and pharmaceutical sciences, will take place at the San Diego Convention Center. Dr. Davidoff's presentation is scheduled for Tuesday, June 4th, at 3:30 pm in Theater 1. It is important to note that the presentation will not be broadcast via webcast.

Those interested in arranging one-on-one meetings with Dr. Davidoff can do so by registering through the BIO International 2024 1-on-1 meeting platform.

XORTX Therapeutics Inc. is a pharmaceutical company with two advanced clinical products: XRx-008, targeting Autosomal Dominant Polycystic Kidney Disease (ADPKD), and XRx-101, aimed at acute kidney and other organ injuries related to respiratory viral infections. Additionally, XORTX is developing XRx-225, a pre-clinical program for Type 2 Diabetic Nephropathy. The company’s research focuses on targeting abnormal purine metabolism and xanthine oxidase to reduce or inhibit uric acid production, with the goal of improving the quality of life and future health of patients with kidney disease.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!